从豆到大脑:咖啡,灰质和神经保护在神经系统疾病的频谱
Videsha Bansal1, Indranath Chatterjee2
1Department of Psychology, Christ University, Bangalore, Karnataka, India.
Progress in brain research
|August 21, 2024
概括
咖啡消费可能会改变大脑结构和功能,潜在地提供神经保护,防止精神分裂症等疾病. 进一步的研究探索了咖啡因.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 咖啡是一种被广泛消费的饮料,其神经效应引起了全球广泛的兴趣.
- 以前的研究表明,咖啡消费与大脑健康之间存在潜在的联系,包括神经保护.
- 神经退行性疾病,如精神分裂症,是复杂的条件,正在进行对促成因素和潜在干预措施的研究.
研究的目的:
- 研究咖啡消费对大脑结构和功能的影响.
- 探索咖啡,特别是咖啡因对神经退行性疾病的潜在神经保护机制.
- 研究咖啡对精神分裂症患者的特定影响,重点关注咖啡因在幻觉中的作用.
主要方法:
- 关于咖啡,大脑功能和神经退行性疾病的现有研究的综合文献综述.
- 对研究咖啡因对与认知和情绪相关的大脑区域的影响的研究分析.
- 探索研究,检查咖啡因摄入量与精神病症状,特别是精神分裂症中的幻觉之间的关系.
主要成果:
- 有证据表明,咖啡消费可以诱导大脑特定区域的大小发生变化,这些区域与情绪和认知有关.
- 咖啡因是咖啡的主要成分,具有调节大脑活动的潜力,并可能对神经衰退提供保护性益处.
- 过度摄入咖啡因与幻觉有关,在精神分裂症的背景下尤其重要.
结论:
- 这项研究确定了咖啡的机制与神经退行性疾病的神经保护之间的潜在联系.
- 了解咖啡对大脑的影响可能为治疗脑部疾病的新治疗策略铺平道路.
- 需要进一步的研究来阐明咖啡消费对大脑健康和疾病预防的长期影响.
相关概念视频
The Blood-brain Barrier
47.0K
Overview
47.0K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Cerebrospinal Fluid
2.0K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
110
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110


